Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2007
03/28/2007EP1443931B1 Ocular iontophoretic device for delivering methotrexate based medicaments and use thereof to treat neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities
03/28/2007EP1414470B1 Micronutrient phosphates as dietary and health supplements
03/28/2007EP0908182B2 Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)
03/28/2007CN1938320A Compounds and methods for treating dyslipidemia
03/28/2007CN1938317A Adiponectin increasing agent
03/28/2007CN1938262A Quaternary ammonium compound, method for production thereof, and therapeutic agent for cerebrovascular disorder and heat disease
03/28/2007CN1938032A Sustained-release oral molsidomine composition for treating atherosclerosis
03/28/2007CN1935839A Analogues of glp-1
03/28/2007CN1935838A Thymosin beta4 derivative and itsuse
03/28/2007CN1935800A Compound with anti cerebralischemia, myo cardialischemia and memory-improving functions, and its preparing method and use
03/28/2007CN1935277A Preparation for the prophylaxis of restenosis
03/28/2007CN1935260A Human antibodies that bind human tnfalpha
03/28/2007CN1935254A Neuregulin for treating cardio vascular disease, and its method and composition
03/28/2007CN1935236A Quality control method for Chinese medicine injection preparation
03/28/2007CN1935235A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935234A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935233A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935232A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935231A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935230A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935229A Chinese medicine injection preparation and its preparing method
03/28/2007CN1935216A Composition containing gynostemma pentaphylla total aglycone and tea polyphenol
03/28/2007CN1935213A Use of total saponinof sapindusmukeossi for preparing clinical medicine
03/28/2007CN1935211A Medicinal composition for treating cerebral ischemia
03/28/2007CN1935208A Medicinal composition of pseudo-ginseng extract and maythorn leaf extract
03/28/2007CN1935207A Composition for preventing and treating hyper blood fat and cardio-cerebrovascular diseases
03/28/2007CN1935199A Quality control method for Chinese medicine compound preparation
03/28/2007CN1935198A Chinese medicine compound preparation and its preparing method
03/28/2007CN1935197A Medicinal composition and its preparing method
03/28/2007CN1935193A Chinese medicine for treating haemorrhoids
03/28/2007CN1935188A Method for preparing injection agent for promoting blood circulation
03/28/2007CN1935186A Compound perillaseed oil and its capsule pill
03/28/2007CN1935183A Chinese medicine compound preparation and its preparing method
03/28/2007CN1935178A Ginkgo leaf extract and barrenwort extract composition
03/28/2007CN1935176A Method for preparing red flower extract containing total red flower uranidin
03/28/2007CN1935172A Medicinal composition and its preparing method
03/28/2007CN1935171A Medicinal composition and its preparing method
03/28/2007CN1935169A Bluish dogbane extract preparing method, and its medicinal preparation and use
03/28/2007CN1935167A Water fennel total phenolic acid preparing process, and medicinal preparation using same as active component and use
03/28/2007CN1935165A Moringaceae tablet and its producing method
03/28/2007CN1935154A Pharmaceutical use of fucoidan for treating cardio-cerebrovascular disease
03/28/2007CN1935150A Pharmaceutical use of vitexin for anti-myocardial ischemia action
03/28/2007CN1935149A Medicinal composition and its preparing method
03/28/2007CN1935148A Medicinal composition and its preparing method
03/28/2007CN1935144A Huangyangning alkaloid and analogue acidic amino acid double salts or composition for treating cardio-cerebrovascular diseases
03/28/2007CN1935128A Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone
03/28/2007CN1935123A Carvedilo oral disintegrating tablet
03/28/2007CN1307300C Hematopoietic stem cells and methods of treatment neogenesis vascular ophthalmopathy
03/28/2007CN1307183C Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
03/28/2007CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog
03/28/2007CN1307179C Pyrimidine derivatives for inhibition of cell proliferation
03/28/2007CN1307176C Novel alkoxypyridine-derivatives
03/28/2007CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands
03/28/2007CN1307174C Imidazoquinoline derivatives
03/28/2007CN1307173C Pyrimidineamines as angiogenesis modulators
03/28/2007CN1307171C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
03/28/2007CN1307166C Oxazole/thiazol-derivatives activators of the HPPAR-alpha receptor
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/28/2007CN1307156C Polyarylcarboxamides useful as lipid lowering agents
03/28/2007CN1306954C Use of a pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
03/28/2007CN1306951C Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and process for preparing the same
03/28/2007CN1306935C Vasopressin antagonist and oxytocin antagonist
03/27/2007USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations
03/27/2007US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis
03/27/2007US7196199 Phenoxypropylamine compounds
03/27/2007US7196118 Amidino compounds useful as nitric oxide synthase inhibitors
03/27/2007US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases
03/27/2007US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
03/27/2007US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents
03/27/2007US7196080 Respiratory system disordeers; chronic obstructive pulminary disease
03/27/2007US7196076 Androgen receptor modulators and methods of use thereof
03/27/2007US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders
03/27/2007US7195870 Diagnosis of diseases associated with gene regulation
03/27/2007US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
03/27/2007US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion
03/27/2007US7195675 Chitosan-containing polysaccharide, method for preparing the same and use thereof
03/27/2007US7195640 Coated medical devices for the treatment of vulnerable plaque
03/27/2007CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1
03/27/2007CA2370244C Piperidine derivatives
03/27/2007CA2208018C Sulfonamides
03/27/2007CA2200084C Use of aromatic halides for treating mammalian cell proliferation
03/27/2007CA2168879C Skin patches and methods for providing testosterone
03/27/2007CA2134966C Antibodies with specificity for multiple adhesion molecules
03/27/2007CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives
03/22/2007WO2007033232A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
03/22/2007WO2007032643A1 A solubilized material comprising ubidecarenone, aqueous solution and process for preparation thereof
03/22/2007WO2007032566A1 Hematopoietic stem cell proliferator
03/22/2007WO2007032561A1 Novel inhibitor of vascular endothelial growth factor expression
03/22/2007WO2007032557A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
03/22/2007WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
03/22/2007WO2007032551A1 Hemodynamics improving agent
03/22/2007WO2007032466A1 Heterocyclic compound, and production process and use thereof
03/22/2007WO2007032445A1 Protein kinase inhibitors
03/22/2007WO2007032160A1 Marker gene for examining hypertension
03/22/2007WO2007031737A1 4,4-dimethylpiperidine-2,6-dione derivatives for use in the treatment of hypertension
03/22/2007WO2007031558A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
03/22/2007WO2007031501A2 Pyridylsulfonamidyl-pyrimidines for the prevention of blood vessel graft failure
03/22/2007WO2007031329A2 Use of a collagen of xenogeneic origin
03/22/2007WO2007030944A2 Methods of cardioprotection using dichloroacetate in combination with an inotrope
03/22/2007WO2007015004A3 Novel crystalline v form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form
1 ... 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 ... 1595